Biomaterials Market worth $88.4 Billion - 2017

Tuesday 9 April 2013, Amsterdam

This report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World. This report also studies the global biomaterial market over the forecast period of 2012-2017. The global market for biomaterials is estimated at $44.0 billion in 2012 and is poised to grow at a CAGR of 15% from 2012 to 2017 to reach $88.4 billion by 2017.

The global biomaterial market is broadly segmented into two categories, by type and by application. The global biomaterial market, by type, is broadly categorized into metals, ceramics, polymers, and natural biomaterials. The biomaterial applications market is broadly segmented into orthopedic, cardiovascular, neurological, dental, tissue engineering, wound healing, plastic surgery, ophthalmology and other applications such as gastrointestinal, urinary, bariatric surgery, and drug delivery system. In 2012, the cardiovascular biomaterial segment contributed 34.5% to the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to witness the highest growth in the coming years.

The biomaterial polymers market is expected to show the highest growth at a CAGR of 22.1% (2012-2017) due to tremendous ongoing research for the development of biodegradable and bio-compatible polymeric biomaterial and its use in a wide range of applications.

North America is the largest biomaterial market and is expected to grow at a high CAGR from the year 2012 to 2017 due to an increase in the aging population. Due to rising awareness of biomaterial products in Asia, and increased conferences and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2012 to 2017.

The report includes company profiles of major players such as DENTSPLY International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. The key raw material supplier companies are Carpenter Technology Corporation (U.S.), Materion Corporation (U.S.), Ulbrich Stainless Steel & Special Metals, Inc. (U.S.), Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), (Germany), Ceradyne, Inc. (U.S.), Kyocera Corporation (Japan), Bayer (Germany), Purac Biomaterials (Netherlands), DSM Biomedical, Inc. (U.S.), Evonik Industries (Germany), Cam Bioceramics (Netherlands), Ticona GmbH (Germany), and Landec Corporation (U.S.).